A detailed history of Guggenheim Capital LLC transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Guggenheim Capital LLC holds 11,499 shares of TNDM stock, worth $425,463. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,499
Previous 10,900 5.5%
Holding current value
$425,463
Previous $439,000 10.93%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$35.21 - $47.3 $21,090 - $28,332
599 Added 5.5%
11,499 $487,000
Q2 2024

Aug 14, 2024

BUY
$30.43 - $53.43 $47,957 - $84,205
1,576 Added 16.9%
10,900 $439,000
Q1 2024

May 14, 2024

BUY
$22.09 - $35.41 $1,723 - $2,761
78 Added 0.84%
9,324 $330,000
Q4 2023

Feb 14, 2024

BUY
$14.28 - $31.03 $132,032 - $286,903
9,246 New
9,246 $273,000
Q2 2023

Aug 11, 2023

BUY
$24.18 - $42.46 $79,576 - $139,735
3,291 Added 55.79%
9,190 $225,000
Q1 2023

May 10, 2023

BUY
$35.86 - $46.5 $211,538 - $274,303
5,899 New
5,899 $239,000
Q3 2022

Nov 14, 2022

SELL
$43.76 - $68.97 $109,968 - $173,321
-2,513 Reduced 24.89%
7,583 $363,000
Q2 2022

Aug 15, 2022

SELL
$53.22 - $123.09 $207,185 - $479,189
-3,893 Reduced 27.83%
10,096 $598,000
Q1 2022

May 16, 2022

SELL
$101.89 - $150.09 $952,671 - $1.4 Million
-9,350 Reduced 40.06%
13,989 $1.63 Million
Q4 2021

Feb 14, 2022

BUY
$118.18 - $153.21 $1.07 Million - $1.39 Million
9,092 Added 63.82%
23,339 $3.51 Million
Q3 2021

Nov 15, 2021

BUY
$93.51 - $129.4 $101,551 - $140,528
1,086 Added 8.25%
14,247 $1.7 Million
Q2 2021

Aug 13, 2021

SELL
$77.0 - $100.19 $10,395 - $13,525
-135 Reduced 1.02%
13,161 $1.28 Million
Q1 2021

May 13, 2021

SELL
$81.28 - $104.34 $23,733 - $30,467
-292 Reduced 2.15%
13,296 $1.17 Million
Q4 2020

Feb 16, 2021

SELL
$86.4 - $121.75 $5,961 - $8,400
-69 Reduced 0.51%
13,588 $1.3 Million
Q3 2020

Nov 13, 2020

SELL
$95.43 - $116.09 $33,782 - $41,095
-354 Reduced 2.53%
13,657 $1.55 Million
Q2 2020

Aug 14, 2020

BUY
$60.05 - $98.92 $465,867 - $767,421
7,758 Added 124.07%
14,011 $1.39 Million
Q1 2020

Jun 02, 2020

BUY
$47.37 - $90.04 $79,392 - $150,907
1,676 Added 36.62%
6,253 $402,000
Q4 2019

Feb 14, 2020

BUY
$53.13 - $71.19 $45,373 - $60,796
854 Added 22.94%
4,577 $273,000
Q3 2019

Nov 14, 2019

SELL
$57.11 - $73.3 $56,253 - $72,200
-985 Reduced 20.92%
3,723 $220,000
Q2 2019

Aug 14, 2019

SELL
$54.41 - $71.7 $71,549 - $94,285
-1,315 Reduced 21.83%
4,708 $304,000
Q1 2019

May 15, 2019

SELL
$32.25 - $73.56 $96,298 - $219,650
-2,986 Reduced 33.14%
6,023 $382,000
Q4 2018

Feb 14, 2019

BUY
$28.45 - $40.65 $256,306 - $366,215
9,009 New
9,009 $342,000
Q2 2018

Aug 14, 2018

SELL
$4.9 - $23.64 $61,465 - $296,540
-12,544 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$2.35 - $4.96 $29,478 - $62,218
12,544 New
12,544 $62,000

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.38B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.